HOME › DRUGS › EMTRICITABINE;TENOFOVIR DISOPROXIL
ACTIVE SUBSTANCE / INN

EMTRICITABINE;TENOFOVIR DISOPROXIL

Brand name(s): Emtricitabine/Tenofovir disoproxil Krka, Emtricitabine/Tenofovir disoproxil Mylan, Truvada, Emtricitabine/Tenofovir disoproxil Krka d.d., Emtricitabine/Tenofovir disoproxil Zentiva
EMA LISTED
AUTHORISED
HIV Infections
ACTIVE SUBSTANCE
Emtricitabine;Tenofovir Disoproxil
REGULATORS
EMA
SPONSORS / MAH
Mylan Pharmaceuticals Limited, Gilead Sciences Ireland UC, Zentiva k.s.
TOTAL APPLICATIONS
5
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TruvadaGilead Sciences Ireland UCAuthorised20/02/2005HIV Infections
Emtricitabine/Tenofovir disoproxil MylanMylan Pharmaceuticals LimitedAuthorised16/12/2016HIV Infections
Emtricitabine/Tenofovir disoproxil ZentivaZentiva k.s.Authorised09/11/2016HIV Infections
Emtricitabine/Tenofovir disoproxil Krka d.d.KRKA, d.d., Novo mestoAuthorised28/04/2017HIV Infections
Emtricitabine/Tenofovir disoproxil KrkaKRKA, d.d., Novo mestoAuthorised09/12/2016HIV Infections

FULL INTELLIGENCE ON EMTRICITABINE;TENOFOVIR DISOPROXIL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →